Before the IV: Why Skin Assessment Should Come First in Vascular Access

When clinicians start an IV, the first instinct is often to look for the best vein. Chris Cavanaugh,
MSN, RN, CRNI, VA-BC, suggests clinicians first take a step back — from the vein to the skin.

Cavanaugh, a vascular access nurse with extensive experience in geriatric and long-term care
populations, presented on this topic at INS 2026 in her session, “Beneath the Dressing:
Managing Skin Conditions and Optimizing Vascular Access Outcomes.” Her message was
clear: skin problems can be just as challenging as vein problems, and skin assessment should
be part of every vascular access decision.

The Overlooked Foundation of Vascular Access

In older adults and patients with chronic illness, skin may already be fragile before a catheter is
placed. Aging reduces collagen and elasticity, making skin more susceptible to injury during
catheter securement and dressing removal. Diabetes can leave skin drier, less supple and
slower to heal. Long-term steroid use can produce “paper-thin” skin that bruises easily and tears when adhesive dressings are removed.

Cavanaugh explains that in patients with fragile skin, the bond between the adhesive and the
skin can be stronger than the skin’s own structural integrity. That observation should change
how clinicians approach vascular access. A catheter cannot remain stable if the dressing cannot adhere to intact skin. Once skin begins to break down, the dressing may lift, shift or fail.
Catheter movement can then contribute to phlebitis, infiltration and infection risk.

The Skin-to-Catheter ‘Death Spiral’

Cavanaugh describes this as a “vascular access death spiral”: skin breakdown leads to dressing failure; dressing failure leads to catheter movement; catheter movement creates a pathway for bacteria; and bacteria can contribute to catheter-related bloodstream infection (CABSI).

That is why medical adhesive-related skin injury, or MARSI, deserves more attention in vascular
access. MARSI is not just a painful skin problem. It can compromise the dressing, the catheter
and the entire access plan.

Cavanaugh believes MARSI remains under-recognized in everyday practice. Although INS
Standards of Practice address vascular access-associated skin injury 1 , she said many facilities do not focus on it.

Clinicians are often “so hyper focused on the vein” that they overlook the body’s largest organ
— the skin — and forget that vessel health and preservation must include skin health.

MARSI Risk Begins Before Dressing Removal

MARSI risk also does not begin only when a dressing is pulled off. Skin breakdown may already
be present before insertion, or it may be triggered by moisture, edema, inadequate barrier
protection, antiseptics that have not fully dried, chronic dermatologic disease, aging skin or
medication-related fragility. Once the skin breaks down, Cavanaugh explained, “there’s nothing
for the dressing left to adhere to.”

The practical takeaway: skin assessment should happen before access, not after problems
appear.


Let the Skin Assessment Guide the Access Plan

For patients with fragile or dermatologic skin conditions, Cavanaugh recommends a deliberate
pre-access assessment. Clinicians should look for skin tears, redness, scarring, plaques from
psoriasis or eczema, keloid scars, edema, moisture, bruising and areas where skin integrity is
already compromised. In patients with darker skin, redness may not be obvious, so clinicians
may need to rely on touch, texture, swelling, warmth and other visual cues.

The assessment may change the access plan. If a patient has psoriasis, eczema or skin
breakdown across the lower arm, a short peripheral IV may not be best. Clearer skin in the
upper arm may support a midline. In some patients, a tunneled central venous catheter may be
more appropriate if the chest offers the only stable skin surface. The goal is to match the device
and dressing strategy to the patient, rather than forcing a planned device into compromised
skin.

Tool provided by Chris Cavanaugh, MSN, RN, CRNI, VA-BC

Before inserting a vascular access device, take a closer look at the skin. This pre-insertion assessment tool helps clinicians identify allergies, existing skin conditions and other risk factors that could affect site selection, antisepsis, dressing adhesion and securement. Its green-yellow-red grading system also provides practical guidance for adapting the care plan to protect skin integrity and reduce the risk of complications, including medical adhesive-related skin injury (MARSI).

Click to download

Treat Dressing Removal as a Procedure

Skin protection also matters at every dressing change. Cavanaugh says removal should be
treated as a procedure, not an afterthought. Her advice is “low and slow”: remove the dressing
carefully, keep the pull parallel to the skin, and avoid lifting upward. Transparent dressings may
release more easily when stretched outward rather than pulled away from the skin.

Cavanaugh also says clinicians need to use “some type of adhesive remover,” particularly when
a dressing is well-adhered or a patient is at risk for skin injury. A dressing that has remained
intact for several days has done so because the adhesive bond is strong. “If you’ve got a
beautiful intact dressing, there’s a reason for that and that adhesive needs something to
release,” she said.

That point matters in vascular access, where dressings must adhere securely enough to protect
the site and stabilize the catheter, but also come off without stripping fragile skin. Cavanaugh
described this as a “double-edged sword”: the stronger the adhesive must be to last several
days, the greater the need for a tool to remove it safely.

She also cautions against relying on alcohol to loosen dressings. While alcohol may release
some adhesives, it can dry and irritate skin and may worsen damage in patients with paper-thin skin, psoriasis, eczema or other vulnerabilities. Barrier film can help protect the skin before
adhesive application, while adhesive remover can help reduce trauma during removal.

Ultimately, Cavanaugh’s message is simple: nurses need to take ownership of the skin. Before
the IV, look at the skin. Before applying a dressing , protect it. Before removing a dressing, plan
the removal as carefully as the insertion. And when skin is fragile, compromised or difficult to
assess, use a structured skin assessment tool to guide site selection, device choice, barrier
protection, adhesive remover and dressing removal technique.

For vascular access clinicians, a consistent skin assessment process can turn “skin first” from a good idea into repeatable bedside practice — one that protects fragile skin, supports dressing
integrity and helps preserve the vascular access device patients depend on.


References

  1. Nickel B, KleidonTM, Alexander M, et al. Infusion therapy standards of practice, 9th edition. J Infus Nurs. 2024;47(suppl 1):S1-S285. doi:10.1097/NAN.0000000000000532

The Next Preventive Frontier May Be Right Under Our Noses

For something we rely on every minute of every day, the nose is remarkably overlooked.

That was the central theme of a recent Vital Stuff conversation between podcaster Gail Lebovic, MD, and Karen Parker-Davidson, DHA-APRN.  This exchange underscored a growing realization in medicine: nasal health is foundational to overall health, not an afterthought.

“We think about breathing only when something goes wrong,” Lebovic noted. “But oxygen is the one thing we can’t live without—even briefly.” The route that oxygen takes, Parker-Davidson emphasized, matters far more than most people realize.

Gail Lebovic, MD
Karen Parker-Davidson, DHA-APRN

The Nose as a Functional and Diagnostic Organ—Not Just a Passageway

Parker-Davidson, a clinician with more than three decades of experience across critical care, ENT, aerospace medicine, and medical devices, reframed the nose as a reactive organ—one with more than 60 distinct functions. Its job is not merely to move air, but to filter, humidify, warm, and regulate airflow before it reaches the lungs.

Nasal resistance is slow and sneaky, she explained, and is often mistaken for congestion. Congestion is acute and obvious. Resistance is cumulative, and insidious—quietly impairing airflow, oxygen exchange, sleep quality, posture, and even facial development over time.

“We can be breathing and still not be breathing well,” Parker-Davidson said.

Continue reading “The Next Preventive Frontier May Be Right Under Our Noses”

ICU Study Finds Simple Adhesive Step Improves Line Security, Cuts Costs

A Simple Idea, Proven by Rigorous Science


A multicenter randomized controlled trial published in Critical Care Medicine is drawing global attention for its practical impact.

The STICKY Trial, led by Australian researcher Nicole Marsh, RN, PhD, found that adding gum mastic liquid adhesive (Mastisol®) to standard jugular central-line dressings:

  • Cut premature dressing failure nearly in half
  • Extended wear time more than two-fold
  • Saved hospitals money
  • And showed promising signals for infection prevention

“Maintaining effective dressing securement of central venous catheters in intensive care is a
clinical priority,” says Dr. Marsh. “Our study demonstrated that Mastisol kept dressings intact longer and reduced unnecessary changes. That means the insertion wound stays continually protected from contamination, and the risk of catheter dislodgement is reduced as well.”

Across four Australian ICUs, 160 critically ill patients with jugular central venous catheters
(CVCs) were enrolled.

Premature dressing failure fell from 50 percent in the control group to 28 percent with Mastisol. Median dressing life increased from 23.8 hours to 58.5 hours, producing an average savings of AUD $11 per patient in material and labor costs.

Continue reading “ICU Study Finds Simple Adhesive Step Improves Line Security, Cuts Costs”

PICC Excellence Launches Ultrasound PIV Mastery Program

Insertion of a peripheral intravenous catheter is the most commonly performed invasive medical procedure among hospitalized patients. When coupled with ultrasound technologies for vascular visualization, well trained clinicians achieve greater first-time procedural success for peripheral IV insertions.

Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC

According to vascular access expert Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC, inconsistent and fragmented training can make it difficult for clinicians to establish competency and master the skills needed to perform successful ultrasound-guided peripheral IV insertions.

To address the lack of standardized UGPIV training, Moureau and her team at PICC Excellence developed a comprehensive training program, which recently became the first educational program to be recognized with a Seal of Approval from the Infusion Nurses Society. The INS Seal of Approval is designed to reflect the credibility of education, competency-based training and content that adheres to INS standards for infusion-related practices (see sidebar below).

Continue reading “PICC Excellence Launches Ultrasound PIV Mastery Program”

The Evolution of Thought Leadership in the MedTech Industry: Insights from Jeff Jones

In the rapidly advancing world of medical technology, establishing credibility and trust is paramount. And one of the best ways to establish that credibility is to seek—and follow—the advice of prominent experts in a particular medtech field. Combined with a strategic public relations strategy, such key opinion leaders (KOLs) can then help raise awareness and provide an invaluable validation of a technology’s importance and value. Together, thought leaders and PR experts enable businesses to gain media exposure, present results at scientific meetings, and secure speaking engagements at industry conferences, thus raising the companies’ visibility and credibility.

Jeffrey Jones, Managing Partner at The Deerborne Group, a global diagnostics and life sciences consulting firm, has learned the importance of key opinion leaders over the course of a long and successful career at both Fortune 500 companies like Abbott, Bayer, and Quest Diagnostics and venture-backed startups like Agendia, which offers genomic testing for breast cancers. Here are his insights:

Continue reading “The Evolution of Thought Leadership in the MedTech Industry: Insights from Jeff Jones”

In Controversy over Transducer Disinfection, Intersocietal Position Statement Earns Broad Support

Over the past decade, there has been a dramatic increase in the adoption of point-of-care (POC) ultrasound to improve patient care across a wide variety of medical specialties, including cardiology, emergency medicine, obstetrics and gynecology, orthopedics, vascular access, and more. But the rapid dissemination of POC ultrasound among new medical specialties, combined with conflicting guidance from clinical organizations, has led to widespread confusion about the infection control practices appropriate for POC ultrasound equipment.

In this blog post, we examine the rise of POC ultrasound, the controversy and confusion surrounding transducer disinfection practices, and the details behind a 2021 Intersocietal Position Statement that provides some much-needed clarity on the topic.

Continue reading “In Controversy over Transducer Disinfection, Intersocietal Position Statement Earns Broad Support”

Knowledge is Power – Why you should #KnowYourBiomarker

Republished with permission from the blog of AJ Patel. This is the second post in a series on advances in genomic testing and the future of cancer treatment — see the first post here.

When I was diagnosed 8 years ago with non-small cell lung cancer (NSCLC), I was told I had 6 months to live. It was the worst time of my life, and I wallowed in misery for nearly a week before I decided I needed to take action. I turned to the internet, which at first did nothing to alleviate my misery. But then I stumbled upon the patient advocacy organization LUNGevity and made a phone call that changed the trajectory of my entire diagnosis.

​That one call—and the connections and information that came out of it—are the reason I’m alive today.

Continue reading “Knowledge is Power – Why you should #KnowYourBiomarker”

Breaking Down Barriers – Improving Access to Comprehensive Biomarker Testing for Cancer Patients

This is the first in a series on advances in genomic testing and the future of cancer treatment.

The last two decades have brought remarkable advances in cancer treatment with the use of precision medicine. Twenty years ago, the major weapon doctors had against most advanced cancers was a harsh regimen of chemotherapy — a one-size-fits-all treatment that leaves patients debilitated while offering limited survival.

The shift to more targeted treatments began after researchers discovered that many cancers are driven by mutations in specific genes. This was most robustly exemplified in non-small cell lung cancer (NSCLC). Pharmaceutical companies have now developed more than two dozen drugs for patients with NSCLC that directly target specific genes and mutations, leading to better overall outcomes.

The impact of these advances “has been enormous,” says Dr. Wendy Levin, Chief Medical Officer at Biofidelity, a cancer diagnostic company. “If we can get a patient on a targeted agent that’s more effective and better tolerated, we know that they will have a major survival advantage.”

Continue reading “Breaking Down Barriers – Improving Access to Comprehensive Biomarker Testing for Cancer Patients”

Is it Time to Move Beyond CLABSI?

When it comes to infection control in vascular access, central line-associated bloodstream infections (CLABSIs) certainly get the most attention. Yet the medical community is increasingly recognizing how infections associated with other types of vascular access devices are putting patients at risk.

Take peripheral IV (PIV) catheters, the most commonly used type of vascular access device. Nearly 90 percent of hospitalized patients require a PIV at some point during their stay, and PIV usage far outnumbers that of central vascular access devices (CVAD). PIVs, therefore, account for an infection rate that approaches the CVAD infection rate in absolute terms.

Yet there is currently no mandatory reporting system for bloodstream infections associated with PIVs in the U.S., making it one of the most underreported types of infections in vascular access. Epidemiologist Robert Garcia, an infection preventionist with 40 years of hospital experience, shares these concerns — and he has a plan to address this significant patient safety issue.

Continue reading “Is it Time to Move Beyond CLABSI?”

2021 INS Standards Highlight Anti-Reflux Technology for Needleless Connectors

Guest post by Nancy Moureau, RN, PhD, CEO of PICC Excellence

In vascular access, needleless connectors (NC) are now recommended worldwide to maintain closed IV systems and promote safety by preventing needlestick injuries. Over the past 25 years, many different NCs have come onto the market, with wide variations in design and function among the various types. As a result, there is a lot of confusion among clinicians regarding the proper use and management of these small yet complex devices, which can have serious patient safety implications.

Fortunately, the Infusion Nurses Society provides some clarity on this issue by significantly expanding its guidance on NCs in the 2021 Infusion Therapy Standards of Practice. This includes clearer definitions of the various types of NC technology and emphasizes the importance of understanding how to use each type properly to minimize blood reflux.

Many clinicians are not aware of the impact blood reflux can have, or view it as a minor issue that can be easily addressed with proper flushing. However, evidence is mounting that reflux is largely avoidable and leads to many complications that seriously impact patient safety.

Continue reading “2021 INS Standards Highlight Anti-Reflux Technology for Needleless Connectors”